News | June 23, 2022
Glenmark Pharmaceuticals to address USFDA’s observation
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Ex-Azithromycin has shown a growth of 8% and 14% in April 2022 and May 2022 respectively
The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
The rally attracted around 250 riders, including professionals and amateurs.
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
Subscribe To Our Newsletter & Stay Updated
